Notably, the high expression of CBX3 was correlated with poor prognosis (disease free survival and overall survival) in pancreatic cancer patients from the TCGA dataset (Fig. 1I-J; Fig. S2). Here, CBX3 is linked to familial pancreatic carcinoma.